Pfizer and Trillium: How a $25M investment led to a $2.3B buyout

Pfizer was in a hurry to seal its takeover of cancer startup Trillium Therapeutics, a relationship that was first sparked after the Big Pharma spied some early clinical data at the American Society of Clinical Oncology (ASCO) annual meeting in June 2020.